Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This is an open-label, phase II study to evaluate the efficacy and safety of Abraxane in
combination with Capecitabine in patients with metastatic colorectal cancer in the second or
third line